Literature DB >> 1369994

Expression in yeast of amino-terminal peptide fusions to hepatitis B core antigen and their immunological properties.

K M Beesley1, M J Francis, B E Clarke, J E Beesley, P J Dopping-Hepenstal, J J Clare, F Brown, M A Romanos.   

Abstract

Hepatitis B core protein (HBcAg) is a potent antigen that gives both a T-cell-dependent and a T-cell-independent antibody response. It has been shown that a foreign epitope can be fused to the amino terminus of HBcAg without affecting particle integrity, and that the resulting chimaeric cores retain the immunogenicity of the foreign epitope. Here we describe the efficient expression in yeast of two different chimaeric cores, carrying epitopes of Foot and Mouth Disease Virus (FMDV) or human chorionic gonadotrophin (hCG), which are candidates for FMD and contraceptive vaccines, respectively. These cores could not be produced in E. coli in soluble form but were expressed to high levels in yeast. We constructed a yeast expression vector that allows rapid production of different chimaeric cores by cloning in cassettes encoding foreign epitopes. Both FMDV and hCG-cores were shown to present the epitopes at the surface of the particles. The FMDV-cores produced in yeast were efficient inducers of neutralising antibodies in guinea-pigs after one low dose.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1369994     DOI: 10.1038/nbt0790-644

Source DB:  PubMed          Journal:  Biotechnology (N Y)        ISSN: 0733-222X


  7 in total

1.  Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope.

Authors:  M Del Val; H J Schlicht; H Volkmer; M Messerle; M J Reddehase; U H Koszinowski
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus.

Authors:  P R Grigera; M Garcia-Briones; O Periolo; J L la Torre; R R Wagner
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

3.  Expression of tetanus toxin fragment C in yeast: gene synthesis is required to eliminate fortuitous polyadenylation sites in AT-rich DNA.

Authors:  M A Romanos; A J Makoff; N F Fairweather; K M Beesley; D E Slater; F B Rayment; M M Payne; J J Clare
Journal:  Nucleic Acids Res       Date:  1991-04-11       Impact factor: 16.971

Review 4.  Use of hepadnavirus core proteins as vaccine platforms.

Authors:  David C Whitacre; Byung O Lee; David R Milich
Journal:  Expert Rev Vaccines       Date:  2009-11       Impact factor: 5.217

5.  Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.

Authors:  R Wagner; H Fliessbach; G Wanner; M Motz; M Niedrig; G Deby; A von Brunn; H Wolf
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

Review 6.  Virus-like particles: the new frontier of vaccines for animal viral infections.

Authors:  Elisa Crisci; Juan Bárcena; María Montoya
Journal:  Vet Immunol Immunopathol       Date:  2012-06-01       Impact factor: 2.046

Review 7.  Virus-like particle-based vaccines for animal viral infections.

Authors:  Elisa Crisci; Juan Bárcena; María Montoya
Journal:  Inmunologia       Date:  2012-10-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.